跳至主要内容
临床试验/ACTRN12617001201369
ACTRN12617001201369已完成未知

Prostate Artery Embolisation Assessment of Safety and Efficacy with preliminary and follow-up urodynamic studies in men with symptomatic benign prostate hyperplasia (P-EASY PLUS)

Wesley Medical Imaging0 个研究点目标入组 105 人开始时间: 2017年8月16日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
Male

入选标准

  • BPH with prostate volume > 40cc
  • Moderate-severe lower urinary tract symptoms (IPSS >8)
  • Peak urinary flow <12ml/sec
  • Obstructive urodynamics
  • Medically refractory lower urinary tract symptoms >6 months
  • Unsuitable for, or unwilling to undergo, surgical prostate resection, in consultation with a urological surgeon

排除标准

  • Prostate malignancy
  • Neurogenic bladder
  • Renal failure eGFR <35ml/min
  • Severe contrast allergy
  • Severe peripheral vascular disease
  • Urethral or bladder pathology

研究者

发起方
Wesley Medical Imaging

相似试验

Prostate Artery Embolisation Assessment of Safety... | 临床试验